Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,915 people get DHR articles and Market Currents by email alert.

Get email alerts on DHR »

DHR

Danaher Corporation

5/23/2013, 11:42 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, April 18, 8:43 AM More on Danaher (DHR -4.6%) Q1: net profit +13% to $691.9M, helped by an investment gain and improved margins of 52.3% vs 51.8%. Core revenues +1%. Expects Q2 GAAP EPS of $0.80-0.85 vs consensus (usually not GAAP) of $0.87; reaffirms 2013 guidance for EPS of $3.32-3.47 vs $3.45. (PR) Comment! [Earnings, Healthcare, On the Move]
Thursday, April 18, 6:04 AM Danaher (DHR): Q1 EPS of $0.75 misses by $0.02. Revenue of $4.4B (+3% Y/Y) misses by $0.1B. (PR) Comment! [Earnings, Breaking News]
Thursday, April 18, 12:05 AM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
Wednesday, April 17, 5:30 PM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
Friday, April 5, 6:27 PM Weakness in commodities is not a sign of a global slowdown, it's actually good for stocks, says Douglas C. Lane & Associates' Sarat Sethi. A lot of “hot money” is moving out of the sector as the dollar rallies and “stuff” gets more expensive, and its likely to flow into growth opportunities as opposed to traditionally defensive sectors like utilities and consumer staples. His recommendations: global manufacturing companies such as Danaher (DHR) and Emerson (EMR), which his firm owns, as well as transports, notably airlines. 6 Comments [Commodities, U.S. Economy]
Friday, March 22, 3:15 PM KKR (KKR -2%) and TPG Capital are apparently no longer planning to bid for Life Technologies (LIFE -0.1%). According to reports, the company is more likely to be sold to a corporate buyer, possibly Danaher (DHR +0.6%) or Thermo Fisher Scientific (TMO -0.9%). LIFE had initially sought a private equity firm to acquire the company in a leveraged buyout, but strategic bidders emerged who may be in better position because opportunities to cut costs mean they could make a higher offer. Comment! [Healthcare, M&A, On the Move]
Tuesday, March 19, 2:01 PM Shares of Life Technologies (LIFE +2.2%) pop on reports that Roche (RHHBY.PK) is weighing a bid. The drug giant joins a host of other potential bidders including: TMO, DHR, and a buyout consortium comprising BX, CG, TPG Capital and Singapore's state investor Temasek Holdings. Comment! [Healthcare, On the Move, M&A]
Tuesday, March 12, 3:55 AM The race to acquire Life Technologies (LIFE) looks to be back in full swing again, with KKR (KKR) reportedly mulling a joint bid with other private-equity firms for the biomedical laboratory equipment maker, which has a market cap of $10.5B. Strategic suitor Thermo Fisher Scientific (TMO) may renew its interest after backing off last month, while Danaher (DHR) is also sniffing around. A group led by Blackstone (BX) and Carlyle (CG) have been rumored to be in talks. Comment! [Healthcare, M&A]
Tuesday, January 29, 6:03 AM Danaher (DHR): Q4 EPS of $0.89 beats by $0.02. Revenue of $4.98B (+5.5% Y/Y). (PR) Comment! [Earnings, Breaking News]
Wednesday, January 9, 2:53 PM Danaher (DHR +4.1%) says it expects to exceed Q4 profit and revenue forecasts, pointing to "broad-based" growth across its business. Previously announced EPS guidance was for between $0.80 and $0.85. Street estimates are for an EPS of $0.83. Comment! [Healthcare, Earnings, On the Move]
Wednesday, January 9, 8:31 AM Danaher (DHR +1.5%) expects Q4 EPS to come in above its previous forecast of $0.80-0.85 - consensus is for $0.83 - and it predicts higher-than-expected core revenue growth. The "strong finish to the year" was "broad-based across most of our businesses," says CEO Lawrence Culp, who's due to present at the JPM healthcare conference today. (PR) Comment! [Earnings]
Wednesday, December 12, 2012, 8:23 AM Ahead of its investor day, Danaher (DHR) forecasts 2013 EPS of $3.40-3.55 vs consensus of 3.50 and core revenue growth of 1-4% (analysts forecast 2012 sales at $18.03B). Also reiterates Q4 EPS of $0.80-0.85 vs expectations of $0.83. "We are focused on gaining market share while remaining active on the acquisition front," says CEO Lawrence Culp. (PR) Comment! [Earnings]
Thursday, October 18, 2012, 8:45 AM More on Danaher (DHR -3.3%) Q3: net income +5% to $548.7M, with last year's results hit by a loss on early debt retirement. Danaher increases estimate for restructuring costs to $120M this year from $100M. Also cuts FY EPS outlook to $3.14-$3.19 from prior guidance of $3.19-$3.26. Consensus is for $3.23. Forecasts Q4 EPS of $0.80-$0.85, below consensus of $0.88. Comment! [Earnings, Healthcare, On the Move]
Thursday, October 18, 2012, 6:06 AM Danaher (DHR): Q3 EPS of $0.77 misses by $0.02. Revenue of $4.42B misses by $90M. (PR) Comment! [Earnings, Tech]
Thursday, October 18, 2012, 12:05 AM Notable earnings before Thursday’s open: BAX, BBT, BSX, BX, CY, DHR, DO, FCS, FITB, GPC, HBAN, KEY, LH, LUV, MS, NOK, NUE, PII, PM, PPG, SVU, TRV, UNP, USG, VZ Comment! [Earnings]
Wednesday, October 17, 2012, 5:30 PM Notable earnings before Thursday’s open: BAX, BBT, BSX, BX, CY, DHR, DO, FCS, FITB, GPC, HBAN, KEY, LH, LUV, MS, NOK, NUE, PII, PM, PPG, SVU, TRV, UNP, USG, VZ 2 Comments [Earnings]